CEO of Henley Healthcare, Michael M. Barbour Wins Entrepreneur of the Year Award
SUGAR LAND, Texas, June 28 /PRNewswire/ -- Henley Healthcare Inc. (Nasdaq: HENL - news) Monday announced that its chief executive officer, Michael M. Barbour, was selected as the healthcare industry's ''Entrepreneur of the Year'' in an awards program in Houston.
Houston's Entrepreneur of the Year Program is one of 47 regional events, sponsored by Ernst & Young, the Entrepreneur of the Year Hall of Fame, The Nasdaq-AMEX Market Group and USA Today. In the fall, the national Entrepreneur of the Year and other national award recipients in 11 other categories will be chosen from among the regional award recipients by an independent, blue ribbon national judging panel.
Barbour was among 10 recipients, in various different industries, selected from approximately 250 nominees for the region.
The national finalists and award recipients will be announced at the International Conference, which will be held in Palm Springs, Calif. on Nov. 11-14. All of the regional award recipients will also be inducted into the Entrepreneur of the Year Hall of Fame at the conference.
Under Barbour's direction, Henley has completed a total of 14 acquisitions and has grown from a research and development company with $500,000 in annual sales to an industry consolidator with revenues of $12.5 million in 1996, $17.6 million in 1997, $41.9 million in 1998 and estimated revenues of $61.2 million for 1999. Their current run rate includes Henley's acquisition of Netherlands-based Enraf-Nonius, a worldwide leader in electrotherapy and ultrasound products. This acquisition positions the company as a global leader in the rapidly growing pain management industry.
Henley Healthcare, a leader in the growing pain management industry, develops, manufactures and distributes products and related accessories used in the control of acute or chronic pain. Henley's diversified line of non-invasive physical medicine and rehabilitation products are used in the treatment of disabilities or injuries with therapeutic exercise and the application of various heat, Fluidotherapy®, traction, ultrasound or other modalities.
The company is also awaiting FDA approval on its MicroLight 830(TM), a hand-held, low-energy (non-surgical) laser for the treatment of repetitive stress injuries such as carpal tunnel syndrome. For additional information on Henley Healthcare, visit their Web site at www.henleyhealth.com.
Contact:
Henley Healthcare Inc.
Ronnie V. Shields, 281-276-7000
Investor Relations
SOURCE: Henley Healthcare Inc. |
